Sage Journals: Discover world-class research

Abstract

Objective

Patients undergoing multiple valve surgery represent a high-risk group who could potentially benefit from a reduction of cross-clamp and cardiopulmonary bypass times because prolonged bypass and cross-clamp times are considered independent risk factors for increased morbidity and mortality after cardiac surgery.

Methods

Between July 2013 and November 2014, 16 patients underwent rapid deployment aortic valve replacement with the EDWARDS INTUITY valve system in the setting of concomitant mitral disease. Fifteen patients showed mitral regurgitation, whereas one patient had severe mitral stenosis. Fourteen patients received mitral valve repair and two patients received biological mitral valve replacement. Tricuspid valve repair was performed additionally in two patients. The mean ± SD age was 72.8 ± 8.4 years, and the mean ± SD logistic EuroSCORE II is 8.7% ± 3.4%.

Results

Within a 30-day perioperative period, no patient was lost (n = 0). The mean ± SD follow-up time was 11 ± 2 months. At 1 year, the overall survival was 81% (n = 13). A mean ± SD transaortic gradient of 10.7 ± 2.3 mm Hg and a mean ± SD effective orifice area of 1.7 ± 0.3 cm² were measured echocardiographically. No higher-grade paravalvular leak (aortic insufficiency > 1+) occurred. Eight patients (61%) had no residual mitral regurgitation, four patients (30%) showed trivial regurgitation (1/4), and one patient (7.3%) had moderate mitral regurgitation (2/4). No interference of the subannular stent frame with the reconstructed valve or the biological mitral prosthesis was seen.

Conclusions

Rapid deployment aortic valve replacement with the EDWARDS INTUITY valve system in combined aortic and mitral valve surgery can be performed safely with reproducible results. One-year follow-up data of this small series shows encouraging results potentially justifying the extension of the indication for rapid deployment valves to patients with concomitant mitral disease. Especially elderly patients undergoing multiple valve surgery may benefit from a reduction of cardiopulmonary bypass and myocardial ischemic times.

Keywords

Valve disease Aortic valve replacement Mitral valve disease

Get full access to this article

View all access options for this article.

References

Schlömicher

, Haldenwang

P.L.

, Moustafine

, Bechtel

, Strauch

J.T.

Minimal access rapid deployment aortic valve replacement: initial singlecenter experience and 12-month outcomes. J Thorac Cardiovasc Surg. 2015; 149: 434–440.

Kocher

A.A.

, Laufer

, Haverich

One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg. 2013; 145: 110–115.

Santarpino

, Pfeiffer

, Schmidt

Sutureless aortic valve replacement: first-year single-center experience. Ann Thorac Surg. 2012; 94: 504–509.

Borger

M.A.

, Moustafine

, Doenst

A randomized multicenter trial of minimally invasive rapid deployment versus conventional full sternotomy aortic valve replacement. Ann Thorac Surg. 2015; 99: 17–25.

Gillinov

A.M.

, Blackstone

E.H.

, Cosgrove

III Mitral valve repair with aortic valve replacement is superior to double valve replacement. J Thorac Cardiovasc Surg. 2003; 25: 1372–1387.

Leavitt

B.J.

, Baribeaun

Y.R.

, DiScipio

A.W.

Outcomes of patients undergoing concomitant aortic and mitral valve surgery in Northern New England. Circulation. 2009; 120(Suppl 1): S155–S162.

Hannan

E.L.

, Racz

M.J.

, Jones

R.H.

Predictors of mortality for patients undergoing cardiac valve replacements in New York State. Ann Thorac Surg. 2000; 70: 1212–1218.

Hellgren

, Kvidal

, Ståhle

Improved early results after heart valve surgery over the last decade. Eur J Cardiothorac Surg. 2002; 22: 904–911.

Galloway

A.C.

, Grossi

E.A.

, Baumann

F.G.

Multiple valve operation for advanced valvular heart disease: results and risk factors in 513 patients. J Am Coll Cardiol. 1992; 19: 725–732.

10.

Al-Sarraf

, Thalib

, Hughes

Cross-clamp time is an independent predictor of mortality and morbidity in low- and high-risk cardiac patients. Int J Surg. 2011; 9: 104–109.

11.

Salis

, Mazzanti

V.V.

, Merli

Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth. 2008; 22: 814–822.

12.

Minh

T.H.

, Mazine

, Bouhout

Expanding the indication for sutureless aortic valve replacement to patients with mitral disease. J Thorac Cardiovasc Surg. 2014; 148: 1354–1359.

13.

Ferrari

, Siniscalchi

, Marinakis

Fast-implantable’ aortic valve implantation and concomitant mitral procedures. Interact Cardiovasc Thorac Surg. 2014; 19: 682–684.

14.

Zoghbi

W.A.

, Chambers

J.B.

, Dumesnil

J.G.

Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2009; 22: 975–1014.

15.

Leon

M.B.

, Piazza

, Nikolsky

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials. J Am Coll Cardiol. 2011; 57: 253–269.

16.

Butchart

E.G.

, Gohlke-Bärwolf

, Antunes

M.J.

Working Groups on Valvular Heart Disease, Thrombosis, and Cardiac Rehabilitation and Exercise Physiology, European Society of Cardiology. Recommendations for the management of patients after heart valve surgery. Eur Heart J. 2005; 26: 2463–2471.

17.

Magovern

G.J.

, Cromie

H.W.

Sutureless prosthetic heart valves. J Thorac Cardiovasc Surg. 1963; 46: 726–736.

18.

Soon

J.L.

, Ye

, Lichtenstein

S.V.

Transapical transcatheter aortic valve implantation in the presence of a mitral prosthesis. J Am Coll Cardiol. 2011; 58: 715–721.

19.

Schlömicher

, Haldenwang

P.L.

, Moustafine

Simultaneous double valve-in-valve TAVI procedure for failed bioprostheses. Ann Thorac Surg. 2015; 99: 722–724.

20.

Beller

C.J.

, Bekeredjian

, Krumsdorf

Transcatheter aortic valve implantation after previous mechanical mitral valve replacement: expanding indications?

Heart Surg Forum. 2011; 14: E166–E170.